"Growing into a Global Healthcare Company" REV-MED [CO. Interview]

실시간 키워드

2022.08.01 00:00 기준

"Growing into a Global Healthcare Company" REV-MED [CO. Interview]

시선뉴스 2025-03-20 09:21:43 신고

South Korea’s export companies serve as a strong foundation for the nation’s economy. This time, we had the opportunity to meet REVMED, a company that has been steadily growing in the healthcare sector and achieving global success. We discussed their values and potential for the future.

REVMED CI [Provided by REVMED]
REVMED CI [Provided by REVMED]

Q. What is the background behind the founding of REVMED?

Twenty years ago, when stem cells first began to attract attention, I developed a deep interest in the field. With extensive experience in healthcare, I founded REVMED with a mission to extend human life and overcome diseases. We focused on developing a system that blocks external contamination, ensuring the safe use of our bio kits for cell separation. Moving forward, we will continue to grow with an unwavering spirit of challenge and innovation.

Q. What are the main business areas of REVMED?

REVMED independently develops and manufactures bio kits that extract and concentrate growth factors and regenerative agents from blood, bone marrow, and adipose tissue. We have obtained patents and regulatory approvals in over 30 countries, expanding our exports worldwide.

Additionally, we are focusing on stem cell-based therapies. With anticipated policy changes, these treatments are expected to contribute to reducing healthcare costs. In 2024, we expanded our business into the medical device sector by launching a medical laser irradiation system.

Q. What gives REVMED a competitive edge?

The NovaStem Bio Kit series, developed by REVMED, offers ease of use with minimal manipulation and ensures high safety through a closed system that prevents external contamination. Designed to concentrate autologous cells present in bone marrow or blood, this product incorporates a patented three-chamber system that efficiently separates red blood cells, which can cause inflammation and side effects, with simple operation.

Company Headquarters Exterior [Provided by REVMED]
Company Headquarters Exterior [Provided by REVMED]

Q. What new businesses are you preparing for future growth?

REVMED is actively investing in expanding into the smart healthcare sector. We have completed the first phase of development for Run & Heal, an application designed to help individuals manage their health conditions effectively, and plan to develop various new businesses based on this platform.

The advanced regenerative biotechnology market has been rapidly expanding since 2020, reflecting growing interest in cell-level regenerative treatments. We aim to provide high-quality bio kits to ensure that patients suffering from conditions previously deemed untreatable receive safe and effective treatment.

Q. What are your future plans and goals?

Over the next 10 to 20 years, REVMED aims to develop treatments for currently incurable diseases. A particular focus is on autoimmune diseases, especially atopic dermatitis, where existing treatments are prohibitively expensive and do not offer a permanent cure. We are committed to developing curative technologies that provide practical solutions for patients struggling to access effective treatments.

Furthermore, we are strengthening our presence in domestic and international markets by collaborating with local partners to secure product certifications and establish marketing strategies. We will continue to expand our lineup of cutting-edge bio products to meet diverse medical needs.

Leveraging our technological expertise, we will enhance research and development efforts to provide safer and more effective healthcare solutions.

Q. What is your management philosophy and core values?

At REVMED, we hold perseverance and innovation as our core values.

The biotech industry demands a commitment of at least a decade to navigate research, clinical validation, and regulatory approvals from multiple national agencies, requiring immense patience and dedication.

Despite these challenges, our entire team remains united by a shared mission to extend human life and combat diseases. Through relentless dedication and teamwork, we have achieved significant milestones and laid the groundwork for becoming a global leader in healthcare. However, we refuse to remain complacent. Our vision is to create an environment within REVMED where everyone can share the dream and turn aspirations into reality.

Companies must continuously adapt and grow within an ever-evolving landscape. Perseverance is key to achieving long-term objectives, and constant innovation is crucial for seizing new opportunities. We maintain an open mindset to embrace change and new ideas, always seeking the best solutions.

Ultimately, a great leader is someone who understands people and empowers them to achieve their best. Guided by this philosophy, we will continue to lead REVMED toward sustained growth and success.

Copyright ⓒ 시선뉴스 무단 전재 및 재배포 금지

본 콘텐츠는 뉴스픽 파트너스에서 공유된 콘텐츠입니다.

다음 내용이 궁금하다면?
광고 보고 계속 읽기
원치 않을 경우 뒤로가기를 눌러주세요

실시간 키워드

  1. -
  2. -
  3. -
  4. -
  5. -
  6. -
  7. -
  8. -
  9. -
  10. -

0000.00.00 00:00 기준

이 시각 주요뉴스

알림 문구가 한줄로 들어가는 영역입니다

신고하기

작성 아이디가 들어갑니다

내용 내용이 최대 두 줄로 노출됩니다

신고 사유를 선택하세요

이 이야기를
공유하세요

이 콘텐츠를 공유하세요.

콘텐츠 공유하고 수익 받는 방법이 궁금하다면👋>
주소가 복사되었습니다.
유튜브로 이동하여 공유해 주세요.
유튜브 활용 방법 알아보기